Red hand letter

DHCP communication on azacitidine 25 mg / ml powder for suspension for injection

DHCP communication on azacitidine 25 mg / ml powder for suspension for injection

Hamburg / Dassow, May 20th, 2021

 

Informing healthcare professionals about the potential risk of incorrect reconstitution (medication errors).


You can find the file here.

Back to the news

AqVida GmbH
Premium Oncology Products
Quality - Made in Germany

 

We are available for current company topics and interview requests:


Saskia Heinze

Claudia Schubert


Phone:  49 (0) 40 / 380 371 9 - 0


Mail: pr@aqvida.com

Hamburg / Dassow, May 20th, 2021

 

Informing healthcare professionals about the potential risk of incorrect reconstitution (medication errors).


You can find the file here.

Back to the news

AqVida GmbH Premium Oncology ProductsQuality - Made in Germany

 

We are available for current company topics and interview requests:


Saskia Heinze

Claudia Schubert


Phone: 49 (0) 40 / 380 371 9 - 0

Mail: pr@aqvida.com

Share by: